AMALGAMATED BANK - VISTAGEN THERAPEUTICS INC ownership

VISTAGEN THERAPEUTICS INC's ticker is VTGN and the CUSIP is 92840H202. A total of 84 filers reported holding VISTAGEN THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
AMALGAMATED BANK ownership history of VISTAGEN THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$4
+33.3%
31,571
+5.5%
0.00%
Q4 2022$3
-99.9%
29,9210.0%0.00%
Q3 2022$5,000
-80.8%
29,921
+1.3%
0.00%
Q2 2022$26,000
-31.6%
29,524
-2.7%
0.00%
Q1 2022$38,000
-70.3%
30,350
-53.7%
0.00%
Q4 2021$128,000
+40.7%
65,548
+98.1%
0.00%
-100.0%
Q3 2021$91,000
-16.5%
33,092
-4.4%
0.00%0.0%
Q2 2021$109,00034,6280.00%
Other shareholders
VISTAGEN THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
ACUTA CAPITAL PARTNERS, LLC 11,728,033$32,135,00011.34%
VR Adviser, LLC 16,047,286$43,970,0005.65%
COMMODORE CAPITAL LP 5,123,509$14,038,0003.70%
Ghost Tree Capital, LLC 2,000,000$5,480,0001.60%
EPIQ PARTNERS, LLC 916,100$2,510,0001.16%
SILVERARC CAPITAL MANAGEMENT, LLC 707,733$1,939,0001.10%
SPHERA FUNDS MANAGEMENT LTD. 3,824,938$10,480,0000.88%
HighVista Strategies LLC 438,239$1,201,0000.80%
Nicholas Investment Partners, LP 2,786,354$7,635,0000.56%
NEA Management Company, LLC 16,302,596$44,669,0000.53%
View complete list of VISTAGEN THERAPEUTICS INC shareholders